Skip to main content
Smart Investors Daily
SN

OTC · SNNAQ

Sienna Biopharmaceuticals, Inc.

Healthcare · Biotechnology

$0.00

Up+$0.00 (+0.00%)

Updated Aug 23, 2026, 7:09 PM

SID Score

5.0/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
3.09K
P/E ratio
-0
Dividend yield
0.00%
52-week range
$0.00 – $0.00
Volume
51.13K
Avg. volume
182

Price performance

SNNAQ price history

1M range · 1 trading sessions · Daily adjusted prices

SNNAQ closed at $0.00 after 1 trading sessions, up 0.00% for the selected period.

No results

At least two price observations are needed to draw this chart.

Latest SNNAQ news

The latest Smart Investors Daily articles mentioning SNNAQ.

SNNAQ research

Overview

Company profile and research snapshot.

Company profile

SIENNA BIOPHARMACEUTICALS

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
SNNAQ recent ratings
DateFirmRatingTarget
Sep 5, 2019BMO CapitalOutperform
May 13, 2019JP MorganNeutral
Dec 4, 2018BMO CapitalOutperform
Aug 1, 2018BMO CapitalOutperform
Dec 6, 2017GuggenheimNeutral
Open full forecast

News briefing

No generated briefing is available yet.

defenseworld.net · Dec 10, 2025

Analyzing Sienna Biopharmaceuticals (OTCMKTS:SNNAQ) & HCW Biologics (NASDAQ:HCWB)

HCW Biologics (NASDAQ: HCWB - Get Free Report) and Sienna Biopharmaceuticals (OTCMKTS:SNNAQ - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability. Analyst Recommendations This is a summary of current

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.